News

Everest Medicines (HKEX: 1952.HK), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines, recently hosted the '2025 ...
The Korea Research Institute of Standards and Science has successfully developed a nanomaterial capable of simultaneously ...
Northwestern’s iSeg tool matches expert doctors and finds hidden cancer zones, with clinical rollout expected soon.
In this week’s edition of InnovationRx, we look at the health impact of the Republican spending bill, a startup that built a hospital in India to test its AI software, the impact of the vaccine panel ...
Read more from Frieden on how Kennedy’s tactics are straight from the anti-vaccine playbook.
Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and ...
Google DeepMind won bragging rights that its competitors in the field of AI could only dream of. A share of the 2024 Nobel Prize in Chemistry was awarded to Demis Hassabis, its CEO, and John Jumper, ...
Initial computational analysis demonstrated that Evaxion's AI-Immunology platform can identify novel vaccine targets to combat Group A Streptococcus (GAS)New vaccine program is added to Evaxion's ...
A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI ...
“It came as a surprise that our approach works so well,” Lu said. In preclinical (non-human) studies, the vaccine completely ...
CureVac shares skyrocketed 35% Thursday when the biotech firm agreed to be bought by COVID-19 vaccine maker BioNTech in an all-stock deal valued at about $1.25 billion.